Antibiogram of Klebsiella Pneumoniae Isolated from Various Clinical Samples of Critically Intensive Care Unit Patients: A Tertiary Care Hospital Based Study from South India
Authors/Creators
- 1. Government Medical College & Government General Hospital, Siddipet, Telangana State, India
- 2. Department of Laboratory Sciences, Krishna Institute of Medical Sciences, Secunderabad, Telangana State, India
Description
Klebsiella associated infections is the emergence of multi-drug resistant strains particularly those involved in nosocomial diseases. Hence, this study has been designed to determine the isolation rate of Klebsiella pneumoniae, their antibiogram in various clinical samples in patients admitted in intensive care units of a tertiary care hospital. A total of 6274 clinical samples were processed during the study period. Out of which 185 (2.94%) Klebsiella pneumoniae isolates were identified from various clinical samples during the study period. It was isolated highest in ET secretion samples (9.73%), followed by urine (2.18%), pus (1.34%) and blood (1.02%). Imipenem (58%) & Meropenem (58%) showed highest sensitivity followed by Amikacin (52%), Gentamicin (35%). Susceptibility to 3rd generation cephalosporins and beta-lactum & betalactamase inhibitor combinations was 10%-20%. We noticed that Klebsiella pneumoniae resistant to a wider range of antibiotics. Both morbidity and mortality is increased when infection is caused by these drug resistant organisms.
Abstract (English)
Klebsiella associated infections is the emergence of multi-drug resistant strains particularly those involved in nosocomial diseases. Hence, this study has been designed to determine the isolation rate of Klebsiella pneumoniae, their antibiogram in various clinical samples in patients admitted in intensive care units of a tertiary care hospital. A total of 6274 clinical samples were processed during the study period. Out of which 185 (2.94%) Klebsiella pneumoniae isolates were identified from various clinical samples during the study period. It was isolated highest in ET secretion samples (9.73%), followed by urine (2.18%), pus (1.34%) and blood (1.02%). Imipenem (58%) & Meropenem (58%) showed highest sensitivity followed by Amikacin (52%), Gentamicin (35%). Susceptibility to 3rd generation cephalosporins and beta-lactum & betalactamase inhibitor combinations was 10%-20%. We noticed that Klebsiella pneumoniae resistant to a wider range of antibiotics. Both morbidity and mortality is increased when infection is caused by these drug resistant organisms.
Files
IJTPR,Vol13,Issue8,Article3.pdf
Files
(871.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:bb88f6e1fb18f8f6280ef1541275d0fa
|
871.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-07-25
Software
References
- 1. Arti K. Ananthanarayan & Panikers Textbook of Microbiology. Chennai: Universities Press Pvt Ltd. 2013; 9th ed. 2. Elmer WK, Stephen DA, Willian MJ, Paul CS & Washington CW. Color Atlas and Textbook of Diagnostic Microbiology. Baltimore: Lippincott Williams Wilkins. 2006; 6th ed. 3. Patrick RM, Barry H, Hazel M. Aucken. Topley & Wilson s Microbiology & Microbial Infections. Salisbury, UK:Edward Arnold Ltd. 2005; 2(10th ed). 4. Shah RK, Singh YI, Sanjana RK, Chaudhary N & Saldanha D. Study of Extended spectrum beta-lactamases (ESBLs) producing Klebsiellaspecies in various clinical specimens: A preliminary report. Journal of College of Medical Sciences-Nepal. 2010; 6(3):19-23. 5. Patrick RM, Barry H, Hazel M. Aucken. Topley & Wilson s Microbiology & Microbial Infections. Salisbury, UK:Edward Arnold Ltd. 2005; 2(10th ed). 6. Pavani G. Drug susceptibility pattern of Klebsiella and Citrobacter infections in India, J. Microbiol. Biotech Res. 2012; 4, 619- 620. 7. Kosmidis C, Poulakou G, Markogiannakis A & Daikos G. Treatments options for infections caused by carbapenem-resistant gram- negative bacteria. Europ. Infect. Dis., 2012; 26:28- 34. 8. Wilberger MS, Anthony KE, Rose S, McClain M & Bermude LE. Beta-Lactam Antibiotic Resistance among Enterobacter spp. Isolated from Infection in Animals," Advanc.Microbiol. 2012; 2:129-137. 9. Christian GG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug resistant gram-negative bacilli. Antimicro. Agents Chemtother. 2008; 52: 813- 821. 10. Bush K. Extended-spectrum β-lactamases in North America. 1987-2006. Clin. Microbiol. Infect. 2008; 14:134-143. 11. Hawkey PM. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin. Microbiol. Infect. 2008; 14:159-165. 12. Wong BA. Therapeutic challenges associated with extended - spectrum - lactamase producing Escherichia coli and Klebsiella pneumonia Pharmacotherapy. 2001; 21: 583 - 92. 13. Cheesbrough M. District laboratory practice in tropical countries. Cambridge university press. 2006. 14. Clinical and Laboratory Standards Institute (CLSI)- Performance standards for antimicrobial susceptibility testing. 2019; 29th ed:1– 319. 15. ARC (Antimicrobial Resistance Collaborators). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 12;399(10325):629-655. 16. Brinkac L, Voorhies A, Gomez A, Nelson KE. The Threat of Antimicrobial Resistance on the Human Microbiome. Microb. Ecol. 2017; 74:1001–1008. 17. Gil-Gil T, Laborda P, Sanz-Garcia F, Hernando-Amado S, Blanco P, Martinez JL. Antimicrobial resistance: A multifaceted problem with multipronged solutions. Microbiology open. 2019; 8: e945. 18. Anes J, Hurley D, Martins M, Fanning S. Exploring the Genome and Phenotype of MultiDrug Resistant Klebsiellapneumoniae of Clinical Origin. Front. Microbiol. 2017; 8:1913. 19. Gill MK, Gill AK, Khanna A. Antibiogram of Klebsiella pneumoniae isolated from various clinical samples of hospitalized patients in a tertiary care hospital of North India. Trop J Pathol Microbiol. 2019;5(8):512- 516. 20. Mohapatra S, Panigrahy R, Tak V, Shwetha JV, Sneha KC et al., Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India. Access Microbiology 2022; 4:000321.